ANLN and intrahepatic cholangiocarcinoma: The subcutaneous xenograft ICC models demonstrated that simvastatin or verteporfin treatment obviously reduced the tumor volume enhanced by ANLN overexpression, but did not affect the weight of the mice (Fig. 7J–M).